Cargando…
HSD111 Prescription Opioid Use Among Cancer Patients before and after the Onset of COVID-19: Evidence from Real-World Data
Autores principales: | Zhou, B., Pathak, M., Rasu, R., Sambamoorthi, U. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256513/ http://dx.doi.org/10.1016/j.jval.2023.03.2644 |
Ejemplares similares
-
Predicting high-risk opioid prescriptions before they are given
por: Hastings, Justine S., et al.
Publicado: (2020) -
Real‐world opioid prescription to patients with serious, non‐malignant, respiratory illnesses and chronic breathlessness
por: Chen, Xinye, et al.
Publicado: (2022) -
Assessment of Postoperative Opioid Prescriptions Before and After Implementation of a Mandatory Prescription Drug Monitoring Program
por: Shenoy, Rivfka, et al.
Publicado: (2021) -
HSD26 Impact of the COVID-19 Pandemic on Real-World Antipsychotic Treatment Patterns in Patients with Schizophrenia
por: Liu, Z, et al.
Publicado: (2022) -
Comparison of Postpartum Opioid Prescriptions Before vs During the COVID-19 Pandemic
por: Steuart, Shelby R., et al.
Publicado: (2023)